Plain-English translation of NCT04804748 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a device called DefiPace, which uses low-energy electrical pulses to treat and prevent abnormal heart rhythms (atrial fibrillation) that can develop after heart surgery. The study will compare how patients do with standard care versus those who receive this new device. The goal is to see if DefiPace can safely and effectively restore normal heart rhythm and prevent these rhythm problems from coming back.
Abnormal heart rhythms are a common complication after heart surgery and can cause symptoms like irregular heartbeat, fatigue, and in some cases, serious health problems. Doctors want to find safer and more effective ways to treat and prevent this condition, and this new device may offer a gentler alternative to current treatments.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll undergo your planned heart surgery as scheduled. Depending on which group you're in, either standard post-surgery care will be documented, or you may receive the DefiPace device to help manage your heart rhythm. The research team will collect information about your recovery while you're in the hospital, and if you develop an abnormal heart rhythm after surgery, you'll receive a follow-up phone call 30 days after discharge to check on how you're doing.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
Austria
Germany